Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AtaiBeckley Inc. - Common Stock
(NQ:
ATAI
)
4.375
+0.055 (+1.27%)
Streaming Delayed Price
Updated: 10:46 AM EDT, May 28, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AtaiBeckley Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations
Today 9:00 EDT
From
AtaiBeckley Inc.
Via
GlobeNewswire
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026
May 27, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
AtaiBeckley Reports First Quarter 2026 Financial Results and Provides Program and Business Update
May 12, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
AtaiBeckley and PsyPAN Receive a Silver Award in 2026 Patient Participant Index, Reflecting Ongoing Commitment to Participant-Informed Research
April 27, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
Small-Cap Medical Stocks: ATAI, CMPS, NDRA, PBM in Focus as U.S. Policy Accelerates Psychedelic Research
April 20, 2026
Via
AB Newswire
AtaiBeckley Joins $3 Trillion CRSP Index and S&P Benchmark Indices Adding Mandatory Passive Fund Ownership to Phase 3 Pipeline Catalyst
March 24, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
BPL-003 Demonstrates Rapid and Durable Antidepressant Effects in Treatment-Resistant Depression; Phase 2a Data Published in Journal of Psychopharmacology; Phase 3 Program on Track for Q2 2026 Initiation
March 17, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
BPL-003 Phase 3 Program Initiation on Track for Q2 2026 Following Successful FDA End-of-Phase 2 Meeting; AtaiBeckley Highlights Key Pipeline Milestones at 2026 Investor Day
March 10, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
ENDRA Life Sciences (NASDAQ: NDRA): The GLP-1 Healthcare Boom Offering Tremendous Opportunity Watch HIMS, ANTX, ATAI, PURR Now!
March 09, 2026
Via
AB Newswire
AtaiBeckley Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business and Clinical Update
March 06, 2026
From
AtaiBeckley Inc.
Via
GlobeNewswire
AtaiBeckley Announces Successful End-of-Phase 2 Meeting for BPL-003 in Treatment-Resistant Depression
March 03, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Announces Positive Topline Results from an Exploratory Phase 2a Trial of EMP-01 (oral R-MDMA) in Social Anxiety Disorder
February 26, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley To Host Virtual Investor Day on March 6, 2026
February 20, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Appoints Michael Faerm as Chief Financial Officer
February 19, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley To Participate in Upcoming Investor Conferences
February 17, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Participates in the 64th Annual ACNP Meeting with Two Scientific Poster Presentations and Hot Topic Presentation
January 16, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference
January 08, 2026
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Completes Redomiciliation to the United States
December 30, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 23, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio
December 11, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London
November 13, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
November 12, 2025
AtaiBeckley solidifies position as a global leader in transformative mental health therapies with a short psychedelic duration
From
AtaiBeckley N.V.
Via
GlobeNewswire
AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression
November 10, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies
November 05, 2025
From
AtaiBeckley N.V.
Via
GlobeNewswire
atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares
October 20, 2025
Cash, cash equivalents, short-term investments and other liquid assets expected to fund operations into 2029, beyond anticipated top-line results from the first Phase 3 clinical trial of BPL-003
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Pricing of Public Offering of Common Shares
October 16, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences Announces Proposed Public Offering of Common Shares
October 16, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression
October 16, 2025
From
atai Life Sciences
Via
GlobeNewswire
atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression
September 23, 2025
From
atai Life Sciences
Via
GlobeNewswire
MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI
September 19, 2025
Via
Investor Brand Network
Topics
Artificial Intelligence
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
